A new survey by the National Community Pharmacists Association found that more than 90% of independent pharmacists may refuse to sell drugs targeted by Medicare Part D negotiations, potentially jeopardizing the Biden administration’s efforts to lower prescription costs.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
